TMCnet News
Research and Markets: Acute Inflammation - Pipeline Review, H2 2013 Research ReportDUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/7hmrjn/acute) has announced the addition of the "Acute Inflammation - Pipeline Review, H2 2013" report to their offering. 'Acute Inflammation - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Acute Inflammation, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Acute Inflammation. Scope - A snapshot of the global therapeutic scenario for Acute Inflammation. - A review of the Acute Inflammation products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature n pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Acute Inflammation pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Key Topics Covered: Introduction Acute Inflammation Overview Therapeutics Development Pipeline Products for Acute Inflammation - Overview Pipeline Products for Acute Inflammation - Comparative Analysis Acute Inflammation - Therapeutics under Development by Companies Acute Inflammation - Therapeutics under Investigation by Universities/Institutes Acute Inflammation - Pipeline Products Glance Early Stage Products Unknown Stage Products Acute Inflammation - Products under Development by Companies Acute Inflammation - Products under Investigation by Universities/Institutes Acute Inflammation - Companies Involved in Therapeutics Development Acute Inflammation - Therapeutics Assessment Drug Profiles ATL-1222 - Drug Profile CGEN-856 - Drug Profile ADC (News - Alert)-1004 - Drug Profile DF-2156A - Drug Profile AN-3485 - Drug Profile PIN-201104 - Drug Profile GB-88 - Drug Profile Distamycin Derivatives - Drug Profile Selective Inhibitor of Pro Inflammatory Cytokine - Drug Profile Appendix Companies Mentioned BioLineRx, Ltd. Forest Laboratories, Inc. Italfarmaco S.p.A. Alligator Bioscience AB Anacor Pharmaceuticals, Inc. Dompe Farmaceutici S.p.A. Peptinnovate Limited For more information visit http://www.researchandmarkets.com/research/7hmrjn/acute About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
|